Literature DB >> 19016094

Reasons for cannabis use: patients with schizophrenia versus matched healthy controls.

Michael Schaub1, Kyra Fanghaenel, Rudolf Stohler.   

Abstract

OBJECTIVE: The aim of the present study was to compare self-reported reasons for cannabis use in patients with schizophrenia with those of matched healthy controls.
METHODS: Thirty-six stable outpatients with schizophrenia treated with atypical antipsychotics and 36 matched controls were included. They completed a questionnaire exploring 15 common reasons for use, established in other studies. results: Overall, patients more frequently agreed with the proposed reasons for use than controls. More specifically, patients with schizophrenia more often stated that they consumed cannabis to fight boredom and to ease social contacts.
CONCLUSIONS: Stable schizophrenia outpatients treated with atypicals do not use cannabis in order to reduce side-effects of medication or symptoms of their disorder. Rather, they used cannabis to overcome a feeling of social exclusion. Therefore, enhancing social participation of cannabis-using patients might be an effective strategy for reducing consumption.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016094     DOI: 10.1080/00048670802512016

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  7 in total

Review 1.  A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis.

Authors:  Rachel Little; Dale D'Mello
Journal:  Innov Clin Neurosci       Date:  2022 Jul-Sep

Review 2.  Cannabis and psychosis/schizophrenia: human studies.

Authors:  Deepak Cyril D'Souza; Richard Andrew Sewell; Mohini Ranganathan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-16       Impact factor: 5.270

3.  Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia.

Authors:  Anna Buadze; Rudolf Stohler; Beate Schulze; Michael Schaub; Michael Liebrenz
Journal:  Harm Reduct J       Date:  2010-09-28

4.  Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.

Authors:  Jennifer L Seddon; Max Birchwood; Alex Copello; Linda Everard; Peter B Jones; David Fowler; Tim Amos; Nick Freemantle; Vimal Sharma; Max Marshall; Swaran P Singh
Journal:  Schizophr Bull       Date:  2015-11-04       Impact factor: 9.306

5.  Reasons for illicit drug use in people with schizophrenia: Qualitative study.

Authors:  Carolyn J Asher; Linda Gask
Journal:  BMC Psychiatry       Date:  2010-11-22       Impact factor: 3.630

6.  Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia.

Authors:  Jan van Amsterdam; Jojanneke Vervloet; Gerdien de Weert; Victor J A Buwalda; Anna E Goudriaan; Wim van den Brink
Journal:  Harm Reduct J       Date:  2018-09-20

7.  Risperidone Provides Better Improvement of Sleep Disturbances Than Haloperidol Therapy in Schizophrenia Patients With Cannabis-Positive Urinalysis.

Authors:  Peta-Gaye L Thomas-Brown; Jacqueline S Martin; Clayton A Sewell; Wendel D Abel; Maxine D Gossell-Williams
Journal:  Front Pharmacol       Date:  2018-07-18       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.